Share on StockTwits

Muscle Pharm Co.. (NASDAQ:MSLP) CEO Brad J. Pyatt acquired 5,358 shares of the company’s stock in a transaction dated Friday, August 22nd. The stock was purchased at an average cost of $12.15 per share, with a total value of $65,099.70. Following the purchase, the chief executive officer now directly owns 563,580 shares of the company’s stock, valued at approximately $6,847,497. The acquisition was disclosed in a filing with the SEC, which is available at this link.

Muscle Pharm Co.. (NASDAQ:MSLP) traded up 0.33% during mid-day trading on Friday, hitting $12.14. 24,162 shares of the company’s stock traded hands. Muscle Pharm Co.. has a one year low of $6.16 and a one year high of $12.40. The stock has a 50-day moving average of $11.55 and a 200-day moving average of $9.11. The company’s market cap is $135.1 million.

Muscle Pharm Co.. (NASDAQ:MSLP) last released its earnings data on Monday, August 4th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.11. On average, analysts predict that Muscle Pharm Co.. will post $0.20 earnings per share for the current fiscal year.

MusclePharm Corporation (NASDAQ:MSLP) is engaged in the business of providing personal fitness training using isometric techniques (Tone in Twenty).

Receive News & Ratings for Muscle Pharm Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Muscle Pharm Co and related companies with Analyst Ratings Network's FREE daily email newsletter.